Localization and characterization of the hypothetical protein CT440 in Chlamydia trachomatis-infected cells

Science China Life Sciences

Volumn 54, Issue 11, 2011, Pages 1048-1054

  Li, ZhongYu ^a   Huang, QiuLin ^b   Su, ShengMei ^a   Zhou, Zhou ^a   Chen, ChaoQun ^a   Zhong, GuangMing ^c   Wu, YiMou ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b THE FIRST AFFILIATED HOSPITAL OF UNIVERSITY OF SOUTH CHINA   (China)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Chlamydia trachomatis; CT440; inclusion membrane protein

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM ANTIBODY; HYBRID PROTEIN; MEMBRANE PROTEIN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL INCLUSION; CHEMISTRY; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; FEMALE; GENETICS; HELA CELL; HUMAN; METABOLISM; MICROBIOLOGY; MOUSE; OPEN READING FRAME; PATHOGENICITY; ULTRASTRUCTURE;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HELA CELLS; HUMANS; INCLUSION BODIES; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; OPEN READING FRAMES; RECOMBINANT FUSION PROTEINS;

EID: 83455211388     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-011-4243-1     Document Type: Article

References (26)

1. Mabey D C, Solomon A W, Foster A. Trachoma. Lancet, 2003, 362: 223-229.
2. Brunham R C, Rey-Ladino J. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol, 2005, 5: 149-161.
3. Belland R, Ojcius D M, Byrne G I. Chlamydia. Nat Rev Microbiol, 2004, 2: 530-531.
4. Kilmarx P H, Mock P A, Levine W C. Effect of Chlamydia trachomatis coinfection on HIV shedding in genital tract secretions. Sex Transm Dis, 2001, 28: 347-348.
5. Mbizvo E M, Msuya S E, Stray-Pedersen B, et al. HIV seroprevalence and its associations with the other reproductive tract infections in asymptomatic women in Harare, Zimbabwe. Int J STD AIDS, 2001, 12: 524-531.
6. Smith J S, Muñoz N, Herrero R, et al. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis, 2002, 185: 324-331.
7. Wallin K L, Wiklund F, Luostarinen T, et al. A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma. Int J Cancer, 2002, 101: 371-374.
8. Hackstadt T. The diverse habitats of obligate intracellular parasites. Curr Opin Microbiol, 1998, 1: 82-87.
9. Hackstadt T, Fischer E R, Scidmore M A, et al. Origins and functions of the chlamydial inclusion. Trends Microbiol, 1997, 5: 288-293.
10. Abdelrahman Y M, Belland R J. The chlamydial developmental cycle. FEMS Microbiol Rev, 2005, 29: 949-959.
11. Carabeo R A, Mead D J, Hackstadt T. Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion. Proc Natl Acad Sci USA, 2003, 100: 6771-6776.
12. Su H, McClarty G, Dong F, et al. Activation of Raf/MEK/ERK/cPLA2 signaling pathway is essential for chlamydial acquisition of host glycerophospholipids. J Biol Chem, 2004, 279: 9409-9416.
13. Zhong G. Chlamydia trachomatis secretion of proteases for manipulating host signaling pathways. Front Microbiol, 2011, 2: 14.
14. Li Z, Chen D, Zhong Y, et al. The chlamydial plasmid-encoded protein pgp3 is secreted into the cytosol of Chlamydia-infected cells. Infect Immun, 2008, 76: 3415-3428.
15. Lei L, Qi M, Budrys N, et al. Localization of Chlamydia trachomatis hypothetical protein CT311 in host cell cytoplasm. Microb Pathog, 2011, 51: 101-109.
16. Qi M, Gong S, Lei L, et al. A Chlamydia trachomatis OmcB C-terminal fragment is released into the host cell cytoplasm and is immunogenic in humans. Infect Immun, 2011, 79: 2193-2203.
17. Li Z, Wu Y, Huang Q, et al. Localization and characterization of hypothetical protein CT358 in the Chlamydia trachomatis-infected cells. Prog Biochem Biophys, 2009, 36: 549-554.
18. Li Z, Zhong Y, Lei L, et al. Antibodies from women urogenitally infected with C. trachomatis predominantly recognized the plasmid protein pgp3 in a conformation-dependent manner. BMC Microbiol, 2008, 8: 90.
19. Xiao Y, Zhong Y, Su H, et al. NF-kappa B activation is not required for Chlamydia trachomatis inhibition of host epithelial cell apoptosis. J Immunol, 2005, 174: 1701-1708.
20. Li Z, Chen C, Chen D, et al. Characterization of fifty putative inclusion membrane proteins encoded in the Chlamydia trachomatis genome. Infect Immun, 2008, 76: 2746-2757.
21. Bannantine J P, Griffiths R S, Viratyosin W, et al. A secondary structure motif predictive of protein localization to the chlamydial inclusion membrane. Cell Microbiol, 2000, 2: 35-47.
22. Rockey D D, Scidmore M A, Bannantine J P, et al. Proteins in the chlamydial inclusion membrane. Microbes Infect, 2002, 4: 333-340.
23. 8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis. Proc Natl Acad Sci USA, 2001, 98: 1160-1165.
24. Toh H, Miura K, Shirai M, et al. In silico inference of inclusion membrane protein family in obligate intracellular parasites chlamydiae. DNA Res, 2003, 10: 9-17.
25. Alzhanov D, Barnes J, Hruby D E, et al. Chlamydial development is blocked in host cells transfected with Chlamydophila caviae incA. BMC Microbiol, 2004, 4: 24.
26. Delevoye C, Nilges M, Dautry-Varsat A, et al. Conservation of the biochemical properties of IncA from Chlamydia trachomatis and Chlamydia caviae: oligomerization of IncA mediates interaction between facing membranes. J Biol Chem, 2004, 279: 46896-46906.